APELLIS PHARMACEUTICALS INC (APLS) Stock Analyst Earnings Estimates
NASDAQ:APLS - Nasdaq - US03753U1060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 66.6M -73.42% | 75.4M 13.21% | 396.591M 425.98% | 782.28M 97.25% | 880.82M 12.60% | 1.12B 27.15% | 1.303B 16.34% | 1.499B 15.04% | 1.769B 18.01% | 1.999B 13.00% | 2.19B 9.55% | 2.389B 9.09% | |
| EBITDA YoY % growth | -534.92M -151.07% | -593.05M -10.87% | -515.337M 13.10% | -168.797M 67.25% | -2.727M 98.38% | 469.68M 17,325.83% | 768.69M 63.66% | 1.139B 48.17% | 1.517B 33.19% | 1.765B 16.35% | 1.209B -31.50% | 1.315B 8.77% | |
| EBIT YoY % growth | -536.3M -150.96% | -594.6M -10.87% | -517.121M 13.03% | -177.818M 65.61% | -77.561M 56.38% | 81.72M 205.36% | 244.11M 198.72% | 394.42M 61.57% | 602.38M 52.73% | 777.55M 29.08% | 925.85M 19.07% | 1.071B 15.68% | |
| Operating Margin | -805.26% | -788.59% | -130.39% | -22.73% | -8.81% | 7.30% | 18.73% | 26.31% | 34.05% | 38.90% | 42.28% | 44.83% | |
| EPS YoY % growth | -8.93 -89.19% | -6.13 31.35% | -4.48 26.92% | -1.74 61.27% | -0.99 42.84% | 0.77 177.99% | 1.88 143.19% | 2.42 28.40% | 3.41 41.36% | 4.55 33.16% | 5.26 15.76% | 5.40 2.62% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 46.12% | -0.36 13.46% | -0.31 -10.86% | -0.29 37.76% | -0.23 41.80% | -0.16 56.97% | -0.06 81.38% | 0.04 115.44% | 0.13 156.45% |
| Revenue Q2Q % growth | 202.32M 38.22% | 202.9M 17.74% | 211.75M 6.04% | 219.89M 11.72% | 230.98M 14.17% | 241.77M 19.16% | 258.2M 21.94% | 272.99M 24.15% | 288.71M 24.99% |
| EBITDA Q2Q % growth | -41.52M 49.82% | -45.798M 25.71% | -37.567M -31.58% | -35.149M 23.47% | 14.81M 135.67% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -37.862M 55.20% | -36.067M 41.91% | -30.516M -3.64% | -28.783M 39.12% | -21.55M 43.08% | -25.194M 30.15% | -15.912M 47.86% | -6.63M 76.97% | -306K 98.58% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.46 60.68% | -0.31 | -0.15 | -50.27% |
| Q2 2024 Q2Q % growth | -0.28 72.55% | -0.33 | 0.05 | 15.16% |
| Q1 2024 Q2Q % growth | -0.42 73.08% | -0.48 | 0.06 | 11.77% |
| Q4 2023 Q2Q % growth | -0.73 51.33% | -0.70 | -0.03 | -4.28% |
| Q3 2023 Q2Q % growth | -1.17 33.14% | -0.87 | -0.30 | -34.09% |
| Q2 2023 Q2Q % growth | -1.02 30.14% | -1.35 | 0.33 | 24.40% |
| Q1 2023 Q2Q % growth | -1.56 -9.86% | -1.49 | -0.07 | -4.46% |
| Q4 2022 Q2Q % growth | -1.50 6.83% | -1.60 | 0.10 | 6.20% |
| Q3 2022 Q2Q % growth | -1.75 23.25% | -1.48 | -0.27 | -17.99% |
| Q2 2022 Q2Q % growth | -1.46 46.32% | -1.39 | -0.07 | -4.87% |
| Q1 2022 Q2Q % growth | -1.42 38.79% | -1.35 | -0.07 | -5.49% |
| Q4 2021 Q2Q % growth | -1.61 -273.12% | -1.57 | -0.04 | -2.63% |
| Q3 2021 Q2Q % growth | -2.28 -27.37% | -1.73 | -0.55 | -31.79% |
| Q2 2021 Q2Q % growth | -2.72 -73.25% | -1.72 | -1.00 | -58.19% |
| Q1 2021 Q2Q % growth | -2.32 -1.31% | -1.62 | -0.70 | -43.34% |
| Q4 2020 Q2Q % growth | 0.93 152.54% | -0.77 | 1.70 | 221.15% |
| Q3 2020 Q2Q % growth | -1.79 -62.73% | -1.61 | -0.18 | -11.07% |
| Q2 2020 Q2Q % growth | -1.57 -40.18% | -1.36 | -0.21 | -15.26% |
| Q1 2020 Q2Q % growth | -2.29 -163.22% | -1.41 | -0.88 | -62.50% |
| Q4 2019 Q2Q % growth | -1.77 | -1.16 | -0.61 | -52.18% |
| Q3 2019 Q2Q % growth | -1.10 | -1.03 | -0.07 | -6.56% |
| Q2 2019 Q2Q % growth | -1.12 | -0.79 | -0.33 | -42.20% |
| Q1 2019 Q2Q % growth | -0.87 | -0.68 | -0.19 | -27.65% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 196.83M 78.29% | 204.36M | -7.53M | -3.68% |
| Q2 2024 Q2Q % growth | 199.685M 110.26% | 194.9M | 4.785M | 2.46% |
| Q1 2024 Q2Q % growth | 172.325M 284.26% | 166.62M | 5.705M | 3.42% |
| Q4 2023 Q2Q % growth | 146.377M 544.83% | 146.47M | -93K | -0.06% |
| Q3 2023 Q2Q % growth | 110.399M 399.54% | 101.04M | 9.359M | 9.26% |
| Q2 2023 Q2Q % growth | 94.969M 482.63% | 71.657M | 23.312M | 32.53% |
| Q1 2023 Q2Q % growth | 44.846M 211.43% | 26.625M | 18.221M | 68.44% |
| Q4 2022 Q2Q % growth | 22.7M -62.35% | 24.921M | -2.221M | -8.91% |
| Q3 2022 Q2Q % growth | 22.1M 287.72% | 22.025M | 75K | 0.34% |
| Q2 2022 Q2Q % growth | 16.3M 2,616.67% | 17.283M | -983K | -5.69% |
| Q1 2022 Q2Q % growth | 14.4M | 12.824M | 1.576M | 12.29% |
| Q4 2021 Q2Q % growth | 60.3M -75.88% | 8.96M | 51.34M | 572.99% |
| Q3 2021 Q2Q % growth | 5.7M 850.00% | 7.37M | -1.67M | -22.66% |
| Q2 2021 Q2Q % growth | 600K | 509.918K | 90.082K | 17.67% |
| Q1 2021 Q2Q % growth | 2.318M | -2.318M | -100.00% | |
| Q4 2020 Q2Q % growth | 250M | 98.008M | 151.992M | 155.08% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.47% | -1.47% | -0.23% | -1.23% |
| Revenue | 3.16% | 3.16% | 0.27% | 0.85% |